207 related articles for article (PubMed ID: 38327268)
1. SARS-CoV-2 and chronic myeloid leukemia: a systematic review.
Ali EA; Al-Sadi A; Al-Maharmeh Q; Subahi EA; Bellamkonda A; Kalavar M; Panigrahi K; Alshurafa A; Yassin MA
Front Med (Lausanne); 2023; 10():1280271. PubMed ID: 38327268
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study.
Ali EA; Khamees I; Abu-Tineh M; Qasim H; Alshurafa A; Ahmed K; Malkawi L; Yassin MA
Cureus; 2022 Apr; 14(4):e23863. PubMed ID: 35411288
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for COVID-19 among healthcare workers. A protocol for a systematic review and meta-analysis.
Dzinamarira T; Mhango M; Dzobo M; Ngara B; Chitungo I; Makanda P; Atwine J; Nkambule SJ; Musuka G
PLoS One; 2021; 16(5):e0250958. PubMed ID: 33945546
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the long-term physical and mental health consequences of SARS-CoV-2 infection: A systematic review and meta-analysis protocol.
Kuodi P; Gorelik Y; Edelstein M
PLoS One; 2022; 17(4):e0266232. PubMed ID: 35381027
[TBL] [Abstract][Full Text] [Related]
6. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review.
Juan J; Gil MM; Rong Z; Zhang Y; Yang H; Poon LC
Ultrasound Obstet Gynecol; 2020 Jul; 56(1):15-27. PubMed ID: 32430957
[TBL] [Abstract][Full Text] [Related]
7. What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?
Delgado N; Torres A
Curr Oncol Rep; 2022 May; 24(5):645-650. PubMed ID: 35218499
[TBL] [Abstract][Full Text] [Related]
8. Associations between SARS-CoV-2 infections and thrombotic complications necessitating surgical intervention: A systematic review.
Ferraro JJ; Reynolds A; Edoigiawerie S; Seu MY; Horen SR; Aminzada A; Hamidian Jahromi A
World J Methodol; 2022 Nov; 12(6):476-487. PubMed ID: 36479312
[TBL] [Abstract][Full Text] [Related]
9. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
10. The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population.
Bonifacio M; Tiribelli M; Miggiano MC; Abruzzese E; Binotto G; Scaffidi L; Cordioli M; Damiani D; Di Bona E; Trawinska MM; Tanasi I; Dubbini MV; Velotta V; Ceccarelli G; Pierdomenico E; Lo Schirico M; Semenzato G; Ruggeri M; Fanin R; Tacconelli E; Pizzolo G; Krampera M
Cancer Med; 2021 Sep; 10(18):6310-6316. PubMed ID: 34464516
[TBL] [Abstract][Full Text] [Related]
11. Single-center study on SARS-CoV-2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization.
Civettini I; Antolini L; Brioschi F; Zambrotta GPM; Guglielmana V; Gambacorti-Passerini C
Cancer Med; 2023 Apr; 12(8):9662-9667. PubMed ID: 37039261
[TBL] [Abstract][Full Text] [Related]
12. Current therapeutic options for coronavirus disease 2019 (COVID-19)-lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol.
Zhang ZL; Zhong H; Liu YX; Le KJ; Cui M; Yu YT; Gu ZC; Gao Y; Lin HW
Ann Transl Med; 2020 Nov; 8(22):1527. PubMed ID: 33313272
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Tixagevimab/Cilgavimab to Prevent COVID-19 (Pre-Exposure Prophylaxis): A Systematic Review and Meta-Analysis.
Alhumaid S; Al Mutair A; Alali J; Al Dossary N; Albattat SH; Al HajjiMohammed SM; Almuaiweed FS; AlZaid MR; Alomran MJ; Alqurini ZS; Alsultan AA; Alhajji TS; Alshaikhnasir SM; Al Motared A; Al Mutared KM; Hajissa K; Rabaan AA
Diseases; 2022 Dec; 10(4):. PubMed ID: 36547204
[TBL] [Abstract][Full Text] [Related]
15. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
medRxiv; 2022 Jan; ():. PubMed ID: 35118480
[TBL] [Abstract][Full Text] [Related]
16. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.
Başcı S; Ata N; Altuntaş F; Yiğenoğlu TN; Dal MS; Korkmaz S; Namdaroğlu S; Baştürk A; Hacıbekiroğlu T; Doğu MH; Berber İ; Dal K; Erkurt MA; Turgut B; Çağlayan M; Ayvalı MO; Çelik O; Ülgü MM; Birinci Ş;
J Oncol Pharm Pract; 2020 Oct; 26(7):1676-1682. PubMed ID: 32854573
[TBL] [Abstract][Full Text] [Related]
17. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
18. Renal artery infarction in the SARS-Cov-2 era: A systematic review of case reports.
Kozyrakis D; Kallinikas G; Zarkadas A; Bozios D; Konstantinopoulos V; Charonis G; Safioleas K; Filios A; Rodinos E; Mytiliniou D; Vlassopoulos G; Gkerzelis I; Filios P
Arch Ital Urol Androl; 2023 Oct; 95(3):11625. PubMed ID: 37791549
[TBL] [Abstract][Full Text] [Related]
19. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]